Additionally, the patient with this EXOSC2 M40T mutation has several chromosomal aberrations that are a hallmark of multiple myeloma, suggesting that these EXOSC2 mutations could be passenger mutations rather than a pathogenic driver of the multiple myeloma. This evidence concerns the gene EXOSC2 and plasma cell myeloma.